A 2013 study Published in the journal Pharmacology involved 21 patients with Crohn’s disease unresponsive to standard IBD treatment. The study was able to demonstrate that an 8-week treatment with tetrahydrocannabinol (THC)-rich cannabis caused a decrease in the Crohn’s disease activity index in 90% of patients without producing significant side effects.
Submit A Case ReportTo submit a new Case Report, please click here
Beyond THC Survey
The SCC has developed a CBD-rich cannabis survey because physicians need to know what patients are experiencing. Are the effects of CBD-rich cannabis and high-THC cannabis noticeably different? If so, how? Patients, collectively, can provide the answers. Learn more...